Cahill Represents Debt Financing Sources for U.S. Renal Care, Inc.
Date: 06/28/19
Cahill represented the initial purchaser in connection with an offering of $505,000,000 aggregate principal amount 10.625% senior notes due 2027 for BCPE Cycle Merger Sub II, Inc., which was merged with and into U.S. Renal Care, Inc., a dialysis provider. Cahill represented the lead arrangers and the administrative agent in connection with a $1,600,000,000 term loan B credit facility and a $150,000,000 revolving credit facility for BCPE Cycle Merger Sub II, Inc., which was merged with and into U.S. Renal Care, Inc. Proceeds from the offering were used to fund the acquisition of U.S. Renal Care, Inc. by Bain Capital Private Equity, LP.